Autologous Insulin Producing cells

The search to find a cure for Type 1 Diabetes has continued with the acquisition of ULB (Universite Libre de Bruxelles) spin-off MaSTherCell by pre-clinical cell therapy and regenerative medicines company Orgenesis Inc (OTC: ORGS) on March 9. Scott Carmer, CEO of Orgenesis North America,...